Gut dysbiosis: How a disrupted microbiome accelerates ageing

Every chronic condition we treat may have a microbial signature – it starts in the gut.
Gut dysbiosis, caused by an imbalance in the gut microbiome can lead to several chronic health conditions.

The gut is more than a digestive organ – it influences immunity, metabolism, and brain function. Around 100 trillion (10¹⁴) microbes line the large intestine – outnumbering human cells nearly tenfold. Together, these microbes form a complex ecosystem – the gut microbiome – with powerful physiological roles. This microbiome breaks down complex carbohydrates, synthesises vitamins, trains immune defences, and helps maintain the intestinal barrier. The gut also regulates inflammation, supports metabolic balance, and influences mood via neurotransmitters like serotonin.

When this microbial ecosystem loses balance- a state called gut dysbiosis – the effects extend well beyond improper digestion. Put simply, a local shift becomes a systemic threat.

What is gut dysbiosis?

The gut hosts a vast community of microbes – bacteria, viruses, and fungi – that work collectively to maintain health. They ferment fibres into short-chain fatty acids, synthesise vitamins K and B12, reinforce the mucosal barrier, and educate immune cells. Their chemical signals travel via the vagus nerve and bloodstream, shaping mood and energy.

Dysbiosis occurs when the community’s composition shifts. Beneficial species decline, harmful ones proliferate, and overall diversity shrinks. This breakdown weakens the gut barrier, allowing toxins to enter the bloodstream, and triggering inflammation that contributes to chronic health problems.

What causes gut dysbiosis?

Microbial balance is sensitive to genes, diet, medication, environmental exposure, infections, and hygiene. When these pressures accumulate, the gut’s finely tuned ecosystem gets disrupted.

Destruction of beneficial microbes: Beneficial taxa such as Lactobacillus and Bifidobacterium drive nutrient sensing, hormone signalling, neurotransmitter synthesis, and redox balance. They strengthen the intestinal barrier and promote immune tolerance, avoiding inflammation. When these species are depleted by antibiotics, low fibre diets, medications, or chronic inflammation, these vital functions begin to break down. Digestion weakens, toxins leak, and immune resilience falls.

Overgrowth of harmful microbes: The gut also harbours pathogenic microbes that normally remain in check. But when the ecosystem is disrupted, potentially pathogenic species such as Clostridium difficile or toxin producing strains of Escherichia coli can flourish. They drive inflammation, release toxic metabolites, and damage tissue, transforming a protective organ into a disease engine.

Loss of microbial diversity: A healthy microbiome thrives on diversity. Diversity naturally declines with age, and ultra-processed diets, chronic stress, toxins, and limited microbial exposure hasten the decline. A less diverse microbiome becomes fragile – easily disturbed, slow to recover, and more prone to inflammatory shifts.

What pushes a balanced gut microbiome over the edge?

Modern life piles on stressors: five stand out.

Ultra-processed, low fibre food: Ultra-processed foods shrink diversity and suppress key butyrate producers (akkermansia muciniphila and faecalibacterium prausnitzii) while fostering pro-inflammatory taxa. They also disrupt the mucus layer and weaken the intestinal barrier, allowing toxins to leak into circulation. They reduce production of short-chain fatty acids like butyrate- the molecule that keeps tight junctions sealed and inflammation in check. Over time, this shift primes the body for metabolic dysfunction, gut permeability (“leaky gut”), and even mood disturbances through the gut–brain axis.

Antibiotics: Antibiotics come with a trade off. While they eliminate harmful pathogens, they also reduce beneficial microbes. This leads to antibiotic-induced dysbiosis: reduced microbial diversity, overgrowth of opportunistic species, and increased antibiotic resistance.

These disruptions can persist for months, or even years – leaving the microbiome less resilient. The effects vary by life stage: early exposure in infancy is linked to allergies, asthma, obesity, and later autoimmune risk. In adults, repeated courses can alter metabolism, impair immunity, and promote overgrowth of resistant strains like C. difficile.

Chronic psychological stress: Stress disrupts the microbiota-gut-brain (MGB) axis; the bi-directional communication loop between gut microbes and the brain. Cortisol and other stress hormones alter gut permeability and nutrient availability – pushing the microbiome into a pro-inflammatory state. This fuels gut inflammation and also impacts brain function, impairing memory, increasing anxiety, and deepening fatigue. Over time, this loop of stress and dysbiosis sets the stage for cognitive decline and mood disorders.

Environmental disruptors: Climate change and pollution are altering the ecosystems we rely on for food, water, and microbial exposure. Rising CO₂ and extreme weather events are depleting soils and changing crops, leaving them with less protein, iron, and zinc. These nutrients support human metabolism, and nourish beneficial gut species like Lactobacillus and Bifidobacterium. When nutrient levels fall, beneficial species decline, allowing more aggressive, pro-inflammatory microbes to dominate.

Pollutants such as arsenic, pesticides, and microplastics act like “stealth antibiotics”, eliminating beneficial microbes while allowing harmful strains to thrive. Warmer waters also increase toxins like methylmercury in fish, which can disrupt gut microbial balance when ingested.

Extreme weather events, including floods, droughts, and heatwaves – contaminate food and water with enteric pathogens like E. coli and Salmonella. Heat stress can also weaken the gut barrier, allowing microbes and toxins into circulation and triggering inflammation.

Low grade infections: Even after symptoms resolve, a gut infection may leave behind a lasting microbial blueprint. They often alter gut oxygen levels and damage the mucus layer, creating a niche for Enterobacteriaceae, including strains of E. coli and Klebsiella.

Normally, these bacteria make up a small fraction of the microbiome, but inflammation allows them to thrive. Why? Inflammation releases molecules they can use to grow. Inflammatory signals release nutrients they can use to grow. At the same time, proteins from damaged tissue become a food source – which they ferment into toxic amines linked to joint pain, fatigue, and brain fog. Beneficial species that produce protective SCFAs (butyrate) are depleted.

Persistent Enterobacteriaceae overgrowth worsens gut barrier dysfunction, promotes inflammation, and raises the risk of chronic conditions including Crohn’s disease, obesity, and mood disorders.

Mechanisms through which gut dysbiosis drives disease

Gut dysbiosis triggers a cascade of changes that contribute to chronic disease.

Microbial metabolic imbalance

The gut microbiome is a metabolic powerhouse. Its metabolites (SCFAs, bile acids, and neurotransmitter precursors) act as chemical messengers between organ systems. When microbial balance is lost, this chemical signalling also breaks down.

  • Loss of SCFAs: Beneficial bacteria (Akkermansia muciniphila and Faecalibacterium prausnitzii) produce short-chain fatty acids (butyrate and propionate). When these species decline, SCFA levels fall, increasing gut permeability, systemic inflammation, and the risk of hypertension, cardiovascular disease, and neurodegeneration.
  • Toxic bile acid build up: In hot and humid environments, reduced Lactobacillus murinus raises secondary bile acids, fuelling pro-inflammatory cytokines and neuroinflammation – an early pathway to disorders like Alzheimer’s and Parkinson’s.
  • Disrupted neurotransmitter production: Certain gut bacteria produce serotonin and dopamine. Dysbiosis disrupts these pathways, contributing to mood disorders and reduced stress resilience.

Impaired intestinal barrier

The intestinal lining selectively allows nutrients in while blocking pathogens and toxins. Dysbiosis weakens this barrier. When toxins and bacterial fragments leak into the bloodstream, the immune system mounts a constant, low grade inflammatory response. This chronic inflammation is a hallmark of ageing and a driver of conditions ranging from insulin resistance to arthritis.

Dysregulated immune system

The gut houses nearly 70-80% of immune cells. It is where the immune system is developed. Dysbiosis confuses these signals.

  • Overgrowth of harmful microbes provokes immune overactivation, setting off inflammation that spills into other organs.
  • This hyperactive immune state contributes to insulin resistance, type 1 and type 2 diabetes, rheumatoid arthritis, autoimmune flares, IBD, autism, mood disorders, gastrointestinal cancers, and accelerated biological ageing.
  • An under stimulated immune system may fail to control pathogens, leaving the body vulnerable to infections.

Gut dysbiosis and its impact on ageing

As we age, multiple systems, including the gut, begin to decline. Microbial diversity drops, and immune regulation becomes less precise. This shift fuels the rise of metabolic disorders, autoimmune risk, and frailty mainly through inflammation. At the same time, levels of reactive oxygen species (ROS) elevate, damaging cells and tissues. Dysbiosis amplifies this oxidative stress – reinforcing a feedback loop that accelerates biological ageing.

What makes centenarians different?

Research on centenarians shows they harbour highly diverse microbiomes, rich in species that produce short-chain fatty acids (SCFAs). Microbial diversity is increasingly recognised as a key biomarker of healthy ageing.

Even a disrupted microbiome can be rebalanced with the right interventions:

  • Feed your gut: A fibre rich diet containing prebiotics like inulin and resistant starches encourages the growth of beneficial microbes.
  • Add reinforcements: Fermented foods and probiotics help reintroduce beneficial strains.
  • Identify and remove triggers: Elimination diets can help uncover food sensitivities that contribute to dysbiosis, allowing the gut to recover.

For severe cases, clinical therapies may be required. Faecal microbiota transplantation (FMT) has shown promise in treating stubborn infections and is being explored for broader applications. SCFA-based postbiotic supplements are also emerging as targeted therapies to support gut health.

For long, the gut has been seen as a downstream player – a consequence of what we eat, how we live, or what we inherit. But the evidence tells a different story. The gut is not a passive recipient of health; it is a powerful initiator of it.

Dysbiosis is not simply a gut problem. The solutions must go beyond symptomatic fixes, toward building environments, routines, and clinical frameworks that protect and regenerate microbial diversity across a lifetime.

To age well, we must start with the gut.

Writer Image
Written by: Kriti Rajesh
  1. Jyoti, N., & Dey, P. (2025). Mechanisms and implications of the gut microbial modulation of intestinal metabolic processes. Npj Metabolic Health and Disease, 3(1). [Link]
  2. Hrncir T. (2022). Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options. Microorganisms, 10(3), 578. [Link]
  3. Zhang, Y. J., Li, S., Gan, R. Y., Zhou, T., Xu, D. P., & Li, H. B. (2015). Impacts of gut bacteria on human health and diseases. International journal of molecular sciences, 16(4), 7493–7519. [Link]
  4. Zhang P. (2022). Influence of Foods and Nutrition on the Gut Microbiome and Implications for Intestinal Health. International journal of molecular sciences, 23(17), 9588. [Link]
  5. Patangia, D. V., Anthony Ryan, C., Dempsey, E., Paul Ross, R., & Stanton, C. (2022). Impact of antibiotics on the human microbiome and consequences for host health. MicrobiologyOpen, 11(1), e1260. [Link]
  6. Sohail, R., Mathew, M., Patel, K. K., Reddy, S. A., Haider, Z., Naria, M., Habib, A., Abdin, Z. U., Razzaq Chaudhry, W., & Akbar, A. (2023). Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review. Cureus, 15(4), e37080. [Link]
  7. Madison, A., & Kiecolt-Glaser, J. K. (2019). Stress, depression, diet, and the gut microbiota: human-bacteria interactions at the core of psychoneuroimmunology and nutrition. Current opinion in behavioral sciences, 28, 105–110. [Link]
  8. Bhardwaj, G., Riadi, Y., Afzal, M., Bansal, P., Kaur, H., Deorari, M., Tonk, R. K., Almalki, W. H., Kazmi, I., Alzarea, S. I., Kukreti, N., Thangavelu, L., & Saleem, S. (2024). The hidden threat: Environmental toxins and their effects on gut microbiota. Pathology, research and practice, 255, 155173. [Link]
  9. Shen, Y., Fan, N., Ma, S. X., Cheng, X., Yang, X., & Wang, G. (2025). Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy. MedComm, 6(5), e70168. [Link]
  10. Hrncir T. (2022). Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options. Microorganisms, 10(3), 578. [Link]
  11.  Petersen, C., & Round, J. L. (2014). Defining dysbiosis and its influence on host immunity and disease. Cellular microbiology, 16(7), 1024–1033. [Link]
  12. Jandhyala, S. M., Talukdar, R., Subramanyam, C., Vuyyuru, H., Sasikala, M., & Nageshwar Reddy, D. (2015). Role of the normal gut microbiota. World journal of gastroenterology, 21(29), 8787–8803. [Link]
  13. Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2014). Irritable bowel syndrome: a microbiome-gut-brain axis disorder?. World journal of gastroenterology, 20(39), 14105–14125. [Link]
  14. Appleton J. (2018). The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health. Integrative medicine (Encinitas, Calif.), 17(4), 28–32 [Link]
  15. Chen, G., Shi, F., Yin, W., Guo, Y., Liu, A., Shuai, J., & Sun, J. (2022). Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions. Frontiers in microbiology, 13, 916765. [Link]
  16. Lotti S, Dinu M, Colombini B, Amedei A, Sofi F. Circadian rhythms, gut microbiota, and diet: Possible implications for health. Nutrition, Metabolism and Cardiovascular Diseases. 2023; 33 (8): 1490–1500. 10.1016/j.numecd.2023.05.009. [Link]
  17. Foster JA, Rinaman L, Cryan JF. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiology of Stress. 2017; 7 124–136. 10.1016/j.ynstr.2017.03.001. [Link]
  18.  Zhao M, Chu J, Feng S, Guo C, Xue B, He K, et al. Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review. Biomedicine & Pharmacotherapy. 2023; 164 114985. 10.1016/j.biopha.2023.114985. [Link]
  19. Bora, S. S., Gogoi, R., Sharma, M. R., Anshu, Borah, M. P., Deka, P., Bora, J., Naorem, R. S., Das, J., & Teli, A. B. (2024). Microplastics and human health: unveiling the gut microbiome disruption and chronic disease risks. Frontiers in cellular and infection microbiology, 14, 1492759. [Link]
  20. Naveed, A., Abdullah, S. Impact of parasitic infection on human gut ecology and immune regulations. transl med commun 6, 11 (2021). [Link]
  21. Cho, Y. K., Lee, J., & Paik, C. N. (2023). Prevalence, risk factors, and treatment of small intestinal bacterial overgrowth in children. Clinical and experimental pediatrics, 66(9), 377–383. [Link]
  22. Zhu, X., Zhang, C., Feng, S., He, R., & Zhang, S. (2024). Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis. Clinical and experimental medicine, 24(1), 39. [Link] 
  23. Lephart, E. D., & Naftolin, F. (2022). Estrogen Action and Gut Microbiome Metabolism in Dermal Health. Dermatology and therapy, 12(7), 1535–1550. [Link]
  24. Haran, J. P., & McCormick, B. A. (2021). ageing, Frailty, and the Microbiome-How Dysbiosis Influences Human ageing and Disease. Gastroenterology, 160(2), 507–523. [Link]
  25. Mostafavi Abdolmaleky, H., & Zhou, J. R. (2024). Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases. Antioxidants (Basel, Switzerland), 13(8), 985. [Link]
  26. Nkeck, J. R., Tchuisseu-Kwangoua, A. L., Pelda, A., Tamko, W. C., Hamadjoda, S., Essama, D. B., Fojo, B., Niasse, M., Diallo, S., & Ngandeu-Singwé, M. (2024). Current Approaches to Prevent or Reverse Microbiome Dysbiosis in Chronic Inflammatory Rheumatic Diseases. Mediterranean journal of rheumatology, 35(2), 220–233. [Link]
  27.  Kowalczyk, P., Sulejczak, D., Kleczkowska, P., Bukowska-Ośko, I., Kucia, M., Popiel, M., Wietrak, E., Kramkowski, K., Wrzosek, K., & Kaczyńska, K. (2021). Mitochondrial Oxidative Stress-A Causative Factor and Therapeutic Target in Many Diseases. International journal of molecular sciences, 22(24), 13384. [Link]
  28. Jiang, S., & Miao, Z. (2023). High-fat diet induces intestinal mucosal barrier dysfunction in ulcerative colitis: emerging mechanisms and dietary intervention perspective. American journal of translational research, 15(2), 653–677. [Link] 
  29. Daft, J. G., & Lorenz, R. G. (2015). Role of the gastrointestinal ecosystem in the development of type 1 diabetes. Pediatric diabetes, 16(6), 407–418. [Link] 
  30. Li, H. Y., Zhou, D. D., Gan, R. Y., Huang, S. Y., Zhao, C. N., Shang, A., Xu, X. Y., & Li, H. B. (2021). Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. Nutrients, 13(9), 3211. [Link]
  31. DeGruttola, A. K., Low, D., Mizoguchi, A., & Mizoguchi, E. (2016). Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflammatory bowel diseases, 22(5), 1137–1150. [Link]
  32. Rondinella, D., Raoul, P. C., Valeriani, E., Venturini, I., Cintoni, M., Severino, A., Galli, F. S., Mora, V., Mele, M. C., Cammarota, G., Gasbarrini, A., Rinninella, E., & Ianiro, G. (2025). The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier. Nutrients, 17(5), 859. [Link]
  33. Lathakumari, R. H., Vajravelu, L. K., Satheesan, A., Ravi, S., & Thulukanam, J. (2024b). Antibiotics and the gut microbiome: Understanding the impact on human health. Medicine in Microecology, 20, 100106. [Link]
  34. Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023). Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. Frontiers in endocrinology, 14, 1130689. [Link]
  35. Gunawan, W. B., Abadi, M. N. P., Fadhillah, F. S., Nurkolis, F., & Pramono, A. (2023). The interlink between climate changes, gut microbiota, and aging processes. Human Nutrition & Metabolism, 32, 200193. [Link]
  36. Litchman, E. (2025). Climate change effects on the human gut microbiome: complex mechanisms and global inequities. The Lancet Planetary Health, 9(2), e134–e144. [Link]
  37. Moreira de Gouveia, M. I., Bernalier-Donadille, A., & Jubelin, G. (2024). Enterobacteriaceae in the Human Gut: Dynamics and Ecological Roles in Health and Disease. Biology, 13(3), 142. [Link]
  38. Mhanna, A., Martini, N., Hmaydoosh, G., Hamwi, G., Jarjanazi, M., Zaifah, G., Kazzazo, R., Haji Mohamad, A., & Alshehabi, Z. (2024). The correlation between gut microbiota and both neurotransmitters and mental disorders: A narrative review. Medicine, 103(5), e37114. [Link]
  39. Wiertsema, S. P., van Bergenhenegouwen, J., Garssen, J., & Knippels, L. M. J. (2021). The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies. Nutrients, 13(3), 886. [Link]
  40. Mousa, W. K., Chehadeh, F., & Husband, S. (2022). Microbial dysbiosis in the gut drives systemic autoimmune diseases. Frontiers in immunology, 13, 906258. [Link]
  41. Tan, C., Yan, Q., Ma, Y., Fang, J., & Yang, Y. (2022). Recognizing the role of the vagus nerve in depression from microbiota–gut–brain axis. Frontiers in Neurology, 13, 1015175. [Link]

Disclaimer: The content on this site is for informational and educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any changes to your health regimen, especially regarding medical conditions, treatments, or supplements. While FOXO provides science-backed insights into longevity, individual health decisions should be made in partnership with your doctor. In case of urgent health concerns, seek immediate medical attention.